Sanjay Subramanian Inozyme Pharma, Inc. (INZY) insider trading activity

Sanjay Subramanian is SVP, CFO & Head of BD of Inozyme Pharma, Inc.. Currently has a direct ownership of 32,888 shares of INZY, which is worth approximately $31,901. The most recent transaction as insider was on Mar 31, 2025, when has been sold 2,490 shares (Common Stock) at a price of $0.77 per share, resulting in proceeds of $1,917. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.9K

8.19% 3M change

8.19% 12M change

Total Value Held $31,901

Sanjay Subramanian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2025	BUY Grant, award, or other acquisition	$1,917 $0.77 p/Share	2,490 Added 7.04%	32,888 Common Stock
Sep 29 2023	BUY Grant, award, or other acquisition	$8,278 $3.57 p/Share	2,319 Added 7.09%	30,398 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	$2,163 $2.21 p/Share	979 Added 3.37%	28,079 Common Stock
Apr 19 2022	BUY Open market or private purchase	$99,999 $3.69 p/Share	27,100 Added 50.0%	27,100 Common Stock

Also insider at

OCGN

Ocugen, Inc. Healthcare

Chief Financial Officer